← All trials
NCT04366063
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Apr 5, 2020
- Primary completion
- Jun 6, 2020
- Completion date
- Dec 10, 2020
- First posted
- Apr 28, 2020
- Last posted
- Apr 30, 2020
- Enrollment
- 60
- Arms / groups
- 3 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Royan InstituteLead sponsor
- University of TehranCollaborator
- Shahid Beheshti University of Medical SciencesCollaborator
- Royan InstituteStudy chair
- Royan InstituteOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.